The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.

The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.

Centrul Medical Sourasky din Tel Aviv va deveni primul centru medical din lume care recrutează pacienți pentru un studiu clinic al unui tratament experimental care vizează…